Advancements in Oncology
Advancements in Oncology
Advertisement
Rami Manochakian, MD, FASCOAdvancements in Oncology | June 14, 2024
Dr. Manochakian discusses the implications of recent phase 3 trials in lung cancer.
View More
Nera Lopetegui-Lia, MDAdvancements in Oncology | June 14, 2024
Dr. Lopetegui-Lia reacts to Dr. Gatti-Mays' breast cancer panel discussion from Advancements in Oncology.
Dr. Margaret Gatti-MaysAdvancements in Oncology | June 13, 2024
Dr. Margaret Gatti-Mays explains what makes The Oncology Brothers' content so important for community oncologists.
Dr. Margaret Gatti-MaysAdvancements in Oncology | June 14, 2024
Dr. Margaret Gatti-Mays explains how to address the most pressing questions in triple-negative breast cancer treatments.
Dr. Margaret Gatti-MaysAdvancements in Oncology | June 14, 2024
Dr. Gatti-Mays discusses how treatment for triple-negative breast cancer has evolved in recent years.
Rami Manochakian, MD, FASCOAdvancements in Oncology | June 13, 2024
Dr. Manochakian discusses the most pressing unanswered questions in lung cancer and how they could be addressed.
Rami Manochakian, MD, FASCOAdvancements in Oncology | June 12, 2024
Dr. Manochakian reflects on progress in lung cancer treatment and why it's critical to bring it to the community setting.
Dr. Margaret Gatti-MaysAdvancements in Oncology | June 12, 2024
Dr. Margaret Gatti-Mays delves into the topic of HER2 tumor expression in breast cancer.
Dr. Margaret Gatti-MaysAdvancements in Oncology | June 12, 2024
Dr. Gatti-Mays talks about the importance of tailoring treatments to individual patients with breast cancer.
Cathy Eng, MD, FACP, FASCOGastroesophageal Cancer | June 11, 2024
Dr. Eng opines on how the ESOPEC study will alter the treatment paradigm for patients with esophageal/GEJ adenocarcinoma.
Cathy Eng, MD, FACP, FASCOColorectal Cancer | June 11, 2024
Dr. Eng comments on how she approaches treatment considerations and management for her younger patients with colon cancer.
Cathy Eng, MD, FACP, FASCOColorectal Cancer | June 11, 2024
Dr. Eng explains how she makes sense of the stage 4 third-line therapy options to administer to her colon cancer patients.
Cathy Eng, MD, FACP, FASCOColorectal Cancer | June 11, 2024
Dr. Eng shares what the COMMIT study suggest about colon cancer and this study's applicability outside of liver metastasis.
Rami Manochakian, MD, FASCOAdvancements in Oncology | June 14, 2024
Dr. Manochakian shared his insights during the Oncology Brothers Advancements in Oncology event.
Cathy Eng, MD, FACP, FASCOColorectal Cancer | June 11, 2024
Dr. Eng provides her thoughts on ctDNA upfront, sequential, and combined with NGS testing for patients with colon cancer.
Cecilia BrownAdvancements in Oncology | June 16, 2024
Dr. Rami Manochakian and The Oncology Brothers discusses treatment for SCLC, which is evolving at a rapid pace.
Cecilia BrownAdvancements in Oncology | June 14, 2024
Dr. Manochakian discusses new data and why next-generation sequencing is a critical step when treating NSCLC.
Rob DillardAdvancements in Oncology | June 7, 2024
Dr. Margaret Gatti-Mays, who specializes in breast cancer, delivers key insights on many breast cancer-related topics.
Talha Ugurlu, MDAdvancements in Oncology | June 12, 2024
Dr. Ugurlu said the event was an inspiring experience that helped him navigate the latest data in oncology.
Cecilia BrownAdvancements in Oncology | June 14, 2024
The Oncology Brothers and Dr. Manochakian discussed the rapid changes in the perioperative treatment landscape for NSCLC.
Advertisement
Advertisement
Advertisement
Latest News

July 12, 2024